Richard Christopher - Dec 2, 2024 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Chief Executive Officer
Signature
/Richard Christopher/
Stock symbol
LEXX
Transactions as of
Dec 2, 2024
Transactions value $
$118,392
Form type
4
Date filed
12/3/2024, 02:03 PM
Previous filing
Sep 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LEXX common shares Purchase $51.2K +22.8K $2.24 22.8K Dec 2, 2024 Direct
transaction LEXX common shares Purchase $67.2K +27.2K +119.03% $2.47 50K Dec 3, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LEXX Stock Options 200K Dec 2, 2024 Common Shares 200K $3.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options are vested as to 50,000 on February 28, 2025 with 6,818 being vested monthly thereafter until November 30, 2026 whereby the balance of 6,822 options will be vested on December 31, 2026